Fonseka CY, Rao DA, Raychaudhuri S. Leveraging blood and tissue CD4+ T cell heterogeneity at the single cell level to identify mechanisms of disease in rheumatoid arthritis. Curr Opin Immunol. 2017;49:27-36. doi:10.1016/j.coi.2017.08.005
Eulenberg P, Köhler N, Blasi T, et al. Reconstructing cell cycle and disease progression using deep learning. Nat Commun. 2017;8(1):463. doi:10.1038/s41467-017-00623-3
Doan M, Vorobjev I, Rees P, et al. Diagnostic Potential of Imaging Flow Cytometry. Trends Biotechnol. 2018;36(7):649-652. doi:10.1016/j.tibtech.2017.12.008
Ashok A, Naaz S, Kota LN, et al. Does retinoic acid reverse cell cycle dysregulation in Alzheimer’s disease lymphocytes? Asian J Psychiatr. 2019;39:174-177. doi:10.1016/j.ajp.2018.08.010
Scally SW, Law SC, Ting YT, et al. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Ann Rheum Dis. 2017;76(11):1915-1923. doi:10.1136/annrheumdis-2017-211300
Paik EJ, O’Neil AL, Ng SY, Sun C, Rubin LL. Using intracellular markers to identify a novel set of surface markers for live cell purification from a heterogeneous hIPSC culture. Sci Rep. 2018;8(1):804. doi:10.1038/s41598-018-19291-4
Kaczorowski KJ, Shekhar K, Nkulikiyimfura D, et al. Continuous immunotypes describe human immune variation and predict diverse responses. Proc Natl Acad Sci U S A. 2017;114(30):E6097-E6106. doi:10.1073/pnas.1705065114
Moffett HF, Cartwright ANR, Kim HJ, et al. The microRNA miR-31 inhibits CD8 T cell function in chronic viral infection. Nat Immunol. 2017;18(7):791-799. doi:10.1038/ni.3755
DeRan M, Pulvino M, Zhao J. Assessing G1-to-S-phase progression after genotoxic stress. Methods Mol Biol. 2011;782:221-30. doi:10.1007/978-1-61779-273-1_16
Hideshima T, Bradner JE, Wong J, et al. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci U S A. 2005;102(24):8567-72. doi:10.1073/pnas.0503221102